Florida-based businessman Danny Gaekwad seeks Trump administration intervention after lack of response from Indian regulators ...

The court directed Sebi to decide on US resident Digvijay ‘Danny’ Gaekwad’s proposed competing offer in accordance with the ...

Hamid Ahmed, CEO of Hamdard Laboratories India, has resigned as an independent director from Religare Enterprises due to ...

Hamid Ahmed, CEO of Hamdard Laboratories India, has resigned from Religare Enterprises' board due to increasing workload in his family business. The resignation comes amidst a contentious open offer ...

A Religare Enterprises minority shareholder has filed an appeal against a Delhi High Courts single judges order that refused ...

The Delhi High Court has allowed the Burman family's open offer for acquiring a stake in Religare Enterprises Ltd to proceed, ...

While declining interim relief, the court directed SEBI to swiftly decide on a competing takeover bid, keeping the stage set ...

Delhi High Court rejects plea to block investors from voting on Rashmi Saluja's re-appointment, allows Burmans' open offer.

Saluja had filed the petition in the high court citing the resolution is illegal and that it violates the Companies Act 2013 ...

Markets took a pause after the recent rally and ended slightly lower on Wednesday. Following an initial uptick, Nifty remained range-bound throughout the session and ultimately settled at 23,686.65.

Orbimed Genesis Master Fund L.P. bought 45,000 shares of Mankind Pharma at Rs 2,555.1 per share, while Copthall Mauritius ...

Net Sales at Rs 1,664.43 crore in December 2024 up 10.19% from Rs. 1,510.58 crore in December 2023. Quarterly Net Loss at Rs.